Table 1.
Characteristics of controls and PCOS women.
| Variable |
Control group (N = 100) |
PCOS group (N = 97) |
P-value |
|---|---|---|---|
| Age (years) | 26.7 ± 6.5 | 27.5 ± 6.03 | 0.455 |
| BMI (kg/m2) | 23.7 ± 2.3 | 28.6 ± 1.9 | <0.05 |
| WHR (cm) | 0.80 ± 0.2 | 0.84 ± 0.11 | <0.05 |
| Fasting glucose (mmol/L) | 4.53 ± 0.6 | 5.76 ± 0.6 | <0.05 |
| Fasting insulin (μU/mL) | 7.2 ± 2.3 | 9.01 ± 3.5 | <0.05 |
| HOMA-IR | 1.48 ± 1.02 | 2.29 ± 2.87 | <0.05 |
| TC (mmol/L) | 4.60 ± 1.1 | 4.99 ± 0.89 | <0.05 |
| HDL (mmol/L) | 1.50 ± 0.5 | 1.65 ± 0.6 | <0.05 |
| LDL (mmol/L) | 2.28 ± 0.73 | 2.86 ± 0.82 | <0.05 |
| TGs (mmol/L) | 1.0 ± 0.60 | 1.48 ± 0.94 | <0.05 |
| LH/FSH | 0.60 ± 0.51 | 1.69 ± 1.21 | <0.05 |
| Testosterone (nmol/L) | 1.4 ± 0.5 | 2.5 ± 0.7 | <0.05 |
Data expressed as mean ± SD; BMI = Body mass index; FPG = Fasting plasma glucose; HOMA-IR = homeostasis model assessment of insulin resistance; TC = Total cholesterol; HDL = High density lipoprotein; LDL = Low density lipoprotein; TG = Triglyceride; FSH = Follicle stimulating hormone; LH = Luteinizing hormone. P < 0.05 versus normal controls.